β2 microglobulin-deficient (B2m(null)) NOD/SCID mice are excellent recipients for studying human stem cell function

Orit Kollet, Amnon Peled, Tamara Byk, Herzl Ben-Hur, Dale Greiner, Leonard Shultz, Tsvee Lapidot

Research output: Contribution to journalArticlepeer-review

Abstract

Human SCID repopulating cells (SRC) are defined based on their functional ability to repopulate the bone marrow of NOD/SCID mice with both myeloid and lymphoid cell populations. The frequency of SRC in umbilical cord blood cells is 1 in 9.3 x 105 mononuclear cells. We report that as few as 8 x 104 human cord blood mononuclear cells transplanted into NOD/SCID/B2m(null) mice resulted in multilineage differentiation in the murine bone marrow, revealing a more than 11-fold higher SRC frequency than in NOD/SCID mice. Moreover, as few as 2 to 5 x 103 CD34+ cells recovered from the bone marrow of primary transplanted NOD/SCID mice were sufficient for engrafting secondary NOD/SCID/B2m(null) mice with SRC, suggesting SRC self-renewal. Thus, by using NOD/SCID/B2m(null) mice as recipients, we established a functional assay for human stem cells capable of engrafting the bone marrow of primary and secondary transplanted immune-deficient mice with SRC, providing a model that better resembles autologous stem cell transplantation. (C) 2000 by The American Society of Hematology.

Original languageEnglish
Pages (from-to)3102-3105
Number of pages4
JournalBlood
Volume95
Issue number10
DOIs
StatePublished - 15 May 2000
Externally publishedYes

Fingerprint

Dive into the research topics of 'β2 microglobulin-deficient (B2m(null)) NOD/SCID mice are excellent recipients for studying human stem cell function'. Together they form a unique fingerprint.

Cite this